1. Home
  2. NEXA vs PVLA Comparison

NEXA vs PVLA Comparison

Compare NEXA & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nexa Resources S.A.

NEXA

Nexa Resources S.A.

HOLD

Current Price

$13.25

Market Cap

1.8B

ML Signal

HOLD

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

HOLD

Current Price

$150.51

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEXA
PVLA
Founded
1956
2015
Country
Luxembourg
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
2017
2013

Fundamental Metrics

Financial Performance
Metric
NEXA
PVLA
Price
$13.25
$150.51
Analyst Decision
Hold
Strong Buy
Analyst Count
5
15
Target Price
$10.40
$171.87
AVG Volume (30 Days)
770.8K
158.2K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
0.93%
N/A
EPS Growth
N/A
52.62
EPS
N/A
N/A
Revenue
N/A
$42,810,000.00
Revenue This Year
$8.69
N/A
Revenue Next Year
N/A
$104,350.18
P/E Ratio
N/A
N/A
Revenue Growth
N/A
65.28
52 Week Low
$4.82
$53.30
52 Week High
$16.89
$161.38

Technical Indicators

Market Signals
Indicator
NEXA
PVLA
Relative Strength Index (RSI) 44.43 50.00
Support Level $11.43 $135.68
Resistance Level $15.03 $158.29
Average True Range (ATR) 0.76 6.90
MACD -0.11 -0.31
Stochastic Oscillator 4.21 63.65

Price Performance

Historical Comparison
NEXA
PVLA

About NEXA Nexa Resources S.A.

Nexa Resources SA operate large-scale, mechanized underground and open pit mines, as well as smelters. The company operates through two segments namely Mining and Smelting. Its Mining segment consists of various operating units includes mineral exploration activities and the production of zinc concentrates, copper concentrates and concentrates. The Smelting segment comprises operating units which include facilities recovering and refining zinc metal out of feed materials such as zinc concentrates or secondary feed materials. It generates maximum revenue from the Smelting segment. Geographically It has a presence in Brazil, Peru, the United States of America, Switzerland, Japan, Argentina, South Korea, Colombia, Vietnam, Malaysia and other countries.

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. Its product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations and cutaneous venous malformations. It operates in single segment.

Share on Social Networks: